Literature DB >> 1657587

Hormonal regulation of cyclic nucleotide phosphodiesterases.

M Conti1, S L Jin, L Monaco, D R Repaske, J V Swinnen.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1657587     DOI： 10.1210/edrv-12-3-218

Source DB:  PubMed          Journal:  Endocr Rev        ISSN： 0163-769X            Impact factor:   19.871


× No keyword cloud information.
  16 in total

Review 1.  Underfill and overflow revisited: mechanisms of nephrotic edema.

Authors:  M H Humphreys; J P Valentin; C Qiu; W Z Ying; W P Muldowney; D G Gardner
Journal:  Trans Am Clin Climatol Assoc       Date:  1993

2.  Atrial natriuretic peptide inhibits mineralocorticoid receptor function in rat colonic surface cells.

Authors:  G Schulman; R Lindemeyer; A Barman; S Karnik; C P Bastl
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Characterization of a catalytic ligand bridging metal ions in phosphodiesterases 4 and 5 by molecular dynamics simulations and hybrid quantum mechanical/molecular mechanical calculations.

Authors:  Ying Xiong; Hai-Ting Lu; Yongjian Li; Guang-Fu Yang; Chang-Guo Zhan
Journal:  Biophys J       Date:  2006-09-01       Impact factor: 4.033

4.  Receptor-mediated stimulation of lipid signalling pathways in CHO cells elicits the rapid transient induction of the PDE1B isoform of Ca2+/calmodulin-stimulated cAMP phosphodiesterase.

Authors:  S Spence; G Rena; M Sullivan; S Erdogan; M D Houslay
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

5.  Characterization of the structures of phosphodiesterase 10 binding with adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate by hybrid quantum mechanical/molecular mechanical calculations.

Authors:  Haiting Lu; Alan C Goren; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2010-05-27       Impact factor: 2.991

6.  Studies on the influence of insulin on cyclic adenosine monophosphate in human vascular smooth muscle cells: dependence on cyclic guanosine monophosphate and modulation of catecholamine effects.

Authors:  M Trovati; P Massucco; L Mattiello; F Cavalot; E M Mularoni; A W Hahn; G Anfossi
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

7.  Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.

Authors:  A J Hadley; M Kumari; P O Cover; J Osborne; R Poyser; J D Flack; J C Buckingham
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

8.  Identification and characterization of the type-IVA cyclic AMP-specific phosphodiesterase RD1 as a membrane-bound protein expressed in cerebellum.

Authors:  Y Shakur; M Wilson; L Pooley; M Lobban; S L Griffiths; A M Campbell; J Beattie; C Daly; M D Houslay
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

9.  Distinctive anatomical patterns of gene expression for cGMP-inhibited cyclic nucleotide phosphodiesterases.

Authors:  R R Reinhardt; E Chin; J Zhou; M Taira; T Murata; V C Manganiello; C A Bondy
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

10.  Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome.

Authors:  J P Valentin; C Qiu; W P Muldowney; W Z Ying; D G Gardner; M H Humphreys
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.